Alcoholic hepatitis: How far are we and where are we going?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Annals of Hepatology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 27236145
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta‐analysis of randomized trials

  2016cited by this paper
• [Role of rifaximin in the treatment of hepatic encephalopathy].

  2016cited by this paper
• Early Liver Transplantation for Severe Alcoholic Hepatitis in the United States—A Single‐Center Experience

  2016cited by this paper
• Role of rifaximin in the treatment of hepatic encephalopathy

  2016cited by this paper
• SIRS at Admission Is a Predictor of AKI Development and Mortality in Hospitalized Patients with Severe Alcoholic Hepatitis

  2016cited by this paper
• Intensive Enteral Nutrition Is Ineffective for Patients With Severe Alcoholic Hepatitis Treated With Corticosteroids.

  2016cited by this paper
• The use of beta‐blockers is associated with the occurrence of acute kidney injury in severe alcoholic hepatitis

  2015cited by this paper
• Combining Data From Liver Disease Scoring Systems Better Predicts Outcomes of Patients With Alcoholic Hepatitis.

  2015cited by this paper
• Prednisolone or pentoxifylline for alcoholic hepatitis.

  2015cited by this paper
• Prednisolone or Pentoxifylline for Alcoholic Hepatitis.

  2015cited by this paper
• Gut-liver axis in alcoholic liver disease.

  2015cited by this paper
• Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis.

  2015cited by this paper
• Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis

  2015cited by this paper
• Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding.

  2015cited by this paper
• A histologic scoring system for prognosis of patients with alcoholic hepatitis.

  2014cited by this paper
• Role of IL-22 in microbial host defense.

  2014cited by this paper
• Utilization of baclofen in maintenance of alcohol abstinence in patients with alcohol dependence and alcoholic hepatitis with or without cirrhosis.

  2014cited by this paper
• IL-22 ameliorates renal ischemia-reperfusion injury by targeting proximal tubule epithelium.

  2014cited by this paper
• Improved Prognosis of Septic Shock in Patients With Cirrhosis: A Multicenter Study*

  2014cited by this paper
• Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort

  2014cited by this paper
• Short-term and long-term causes of death in patients with alcoholic hepatitis in Denmark.

  2014cited by this paper
• Invasive aspergillosis in patients with severe alcoholic hepatitis.

  2014cited by this paper
• Treatment with metadoxine and its impact on early mortality in patients with severe alcoholic hepatitis.

  2014cited by this paper
• CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis

  2014cited by this paper
• Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.

  2013cited by this paper
• Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course

  2013cited by this paper
• Alcohol consumption as a cofactor for other liver diseases

  2013cited by this paper
• PNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis

  2013cited by this paper
• Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.

  2013cited by this paper
• Determinants of long‐term outcome in severe alcoholic hepatitis

  2013cited by this paper
• Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis

  2013cited by this paper
• Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).

  2012cited by this paper
• Alcoholic liver disease.

  2012cited by this paper
• Transcriptome analysis identifies TNF superfamily receptors as potential therapeutic targets in alcoholic hepatitis

  2012cited by this paper
• Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis.

  2012cited by this paper
• EASL clinical practical guidelines: management of alcoholic liver disease.

  2012cited by this paper
• Interleukin‐22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice

  2012cited by this paper
• Feasibility and performance of the FibroScan XL probe

  2012cited by this paper
• Patatin‐like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma

  2011cited by this paper
• Validation of prognostic scores for clinical use in patients with alcoholic hepatitis

  2011cited by this paper
• Alcoholic liver disease: pathogenesis and new targets for therapy

  2011cited by this paper
• Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.

  2011cited by this paper
• Alcoholic liver disease: pathogenesis and new therapeutic targets.

  2011cited by this paper
• Early liver transplantation for severe alcoholic hepatitis.

  2011cited by this paper
• Innate immunity in alcoholic liver disease.

  2011cited by this paper
• Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians

  2010cited by this paper
• Patatin-like phospholipase domain containing 3基因多型性與第二型糖尿病的巨量白蛋白尿之關聯性

  2009cited by this paper
• Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.

  2009cited by this paper
• Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.

  2009cited by this paper
• A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis

  2009cited by this paper
• A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis.

  2008cited by this paper
• Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids.

  2008cited by this paper
• Systematic review: glucocorticosteroids for alcoholic hepatitis – a Cochrane Hepato‐Biliary Group systematic review with meta‐analyses and trial sequential analyses of randomized clinical trials

  2008cited by this paper
• A New Scoring System for Prognostic Stratification of Patients With Alcoholic Hepatitis

  2008cited by this paper
• Role of Neutrophils in the Pathogenesis of Acute Inflammatory Liver Injury

  2007cited by this paper
• The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids

  2007cited by this paper
• Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features

  2007cited by this paper
• [Comparison of model for end-stage liver disease score with discriminant function and child-Turcotte-Pugh scores for predicting short-term mortality in Korean patients with alcoholic hepatitis].

  2007cited by this paper
• Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.

  2007cited by this paper
• Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure

  2006cited by this paper
• Alcoholic liver disease.

  2006cited by this paper
• Role of ethanol in the regulation of hepatic stellate cell function.

  2006cited by this paper
• Apoptosis in alcoholic and nonalcoholic steatohepatitis.

  2005cited by this paper
• MELD accurately predicts mortality in patients with alcoholic hepatitis

  2005cited by this paper
• Rationale for combining acamprosate and naltrexone for treating alcohol dependence.

  2005cited by this paper
• Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis.

  2005cited by this paper
• Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial

  2005cited by this paper
• Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score

  2005cited by this paper
• A double‐blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis

  2004cited by this paper
• The role of AMP-activated protein kinase in the action of ethanol in the liver.

  2004cited by this paper
• Interleukin 22 (IL‐22) plays a protective role in T cell‐mediated murine hepatitis: IL‐22 is a survival factor for hepatocytes via STAT3 activation

  2004cited by this paper
• A randomized placebo controlled trial of vitamin E for alcoholic hepatitis.

  2004cited by this paper
• Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis.

  2003cited by this paper
• Propylthiouracil for alcoholic liver disease.

  2002cited by this paper
• Anabolic-androgenic steroids for alcoholic liver disease: a Cochrane Review

  2002cited by this paper
• Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

  2000cited by this paper
• Stellate cell activation in alcoholic fibrosis--an overview.

  1999cited by this paper
• Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

  1998cited by this paper
• Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone.

  1996cited by this paper
• Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables.

  1995cited by this paper
• Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies.

  1995cited by this paper
• A randomized trial of prednisolone in patients with severe alcoholic hepatitis.

  1992cited by this paper
• Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial.

  1989cited by this paper
• Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis.

  1982cited by this paper
• Effects of ethanol on lipid metabolism.

  1979cited by this paper
• Effect of short-term therapy with propylthiouracil in patients with alcoholic liver disease.

  1979cited by this paper
• Corticosteroid therapy of alcoholic hepatitis.

  1978cited by this paper
• Adrenocorticosteroid therapy in alcoholic hepatitis

  1977cited by this paper
• Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial.

  1971cited by this paper

• Meta-analysis of the Effects of Probiotics on Alcoholic Liver Disease.

  2025cites this paper
• Betaine regulates the gut-liver axis: a therapeutic approach for chronic liver diseases

  2025cites this paper
• Bacterial Infection Features in Alcohol-Associated Hepatitis: Review of a 2016–2021 Cohort

  2024cites this paper
• Should responsibility be used as a tiebreaker in allocation of deceased donor organs for patients suffering from alcohol-related end-stage liver disease?

  2023cites this paper
• SQSTM1/p62 and Hepatic Mallory-Denk Body Formation in Alcohol-Associated Liver Disease

  2023cites this paper
• Loss of SQSTM1/p62 Induces Obesity and Exacerbates Alcohol-Induced Liver Injury in Aged Mice

  2023cites this paper
• Management of Alcohol-Related Liver Disease and Its Complications

  2022cites this paper
• The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study

  2021cites this paper
• Emerging Roles of Impaired Autophagy in Fatty Liver Disease and Hepatocellular Carcinoma

  2021cites this paper
• Impact of alcohol abstinence on survival after hepatic resection for hepatocellular carcinoma in patients with alcohol-related liver disease

  2021cites this paper
• Chronic Alcoholic Liver Disease and Mortality Risk in Spontaneous Bacterial Peritonitis: Analysis of 6,530 Hospitalizations

  2020cites this paper
• A novel mouse model of acute-on-chronic cholestatic alcoholic liver disease: A systems biology comparison with human alcoholic hepatitis.

  2019cites this paper
• Histopathological and molecular signatures of a mouse model of acute-on-chronic alcoholic liver injury demonstrate concordance with human alcoholic hepatitis.

  2018cites this paper
• Alcohol Use Disorder, Liver Transplantation and Ethics.

  2017cites this paper
• [Alcohol and cancer: an undervalued problem in prevention programmes].

  2016cites this paper